Amarante, I., Faustino, C., Mota, B., Cascais, M., Almeida, J., & Valentim, M. (2025). Full recovery over one year of the overlap syndrome scleromyositis to maintenance therapy with mycophenolate mofetil and rituximab, which relapsed within 8 months of discontinuation. European Journal of Case Reports in Internal Medicine, 12(5). https://doi.org/10.12890/2025_005154